CHRO EXECUTIVE WORKSPACE · SYNTHETIC DEMO

Board Report

Work analysis, not busyness scoring

BOARD DECISIONS REQUIRED

Approve a bounded Sales opportunity-management pilot

Investment: £225k · expected value: £402k · Sales capacity redeployed · 82% confidence · Human Decision required

Fund workflow-owner and AI control reskilling

Investment: included in implementation · workforce transition: reskilling · 74% confidence · Human Decision required

Do not proceed with Marketing automation until evidence is sufficient

Investment: £0 · expected value: not validated · workforce impact: none · 39% confidence · Approval blocked

Total risk-adjusted realisable portfolio value£982,000

ⓘ All eligible opportunities across the portfolio.

Headline opportunity — NOW priorities£687,000

ⓘ Headline NOW priorities: Sales and Customer Service only; this is a subset of the portfolio.

Future workforce5 roles changingEvidence & assumptions →

Investment case7-month paybackEvidence & assumptions →

Opportunity mix

NOW: 2 · PILOT: 1 · PREPARE: 1 · DO NOT PROCEED: 1

Human judgement retained; administration shifts to bounded AI; reskilling precedes structural options.

Conservative → Base Case → Accelerated: value grows with effectiveness and adoption, with sensitivity visible.

0–3: governance · 3–6: pilot · 6–12: scale controls · 12–24: outcome validation.

Scope: 3,000 employees across seven functions and five countries.
Evidence coverage: 89%.
Risk-adjusted realisable value: £982,000; investment: £650,000; forecast ROI: 51%.
Future workforce: 5 roles materially change; capacity is not assumed to be redundancy.

NOW: Opportunity management — £402,000 realisable value; AI Agent.
NOW: Case administration — £285,000 realisable value; AI Agent.
PILOT: Data reconciliation — £180,000 realisable value; Copilot.
PREPARE: HR administration — £115,000 realisable value; Workflow Redesign.
DO NOT PROCEED: Campaign content production — £0 realisable value; Do Not Proceed.

Decision Assurance: evidence coverage and quality controls are insufficient.
Every recommendation carries evidence, assumptions, confidence and human approval requirements.

Baseline and target measures for output, cycle time, quality, adoption and financial value.
Attribution caution and forecast-accuracy tracking are mandatory.